BRADTEM

This brand name is authorized in Nigeria

Active ingredients

The drug BRADTEM contains a combination of these active pharmaceutical ingredients (APIs):

1 Dihydroartemisinin UNII 6A9O50735X - ARTENIMOL
Artemisinin is used in the treatment of malaria due to species Plasmodium. Read about Artemisinin
2 UNII 854D7K8LXB - PIPERAQUINE PHOSPHATE
Read about

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
P01BF07		P Antiparasitic products, insecticides and repellents → P01 Antiprotozoals → P01B Antimalarials → P01BF Artemisinin and derivatives, combinations
Discover more medicines within P01BF07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: NG	Registered Drug Product Database	Identifier(s): A11-0979

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.